132 related articles for article (PubMed ID: 11068747)
21. [Advance in the study on the proteasome activator PA28].
Murata S; Chiba T
Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1832-40. PubMed ID: 10936967
[No Abstract] [Full Text] [Related]
22. Intracellular localization of proteasomal degradation of a viral antigen.
Antón LC; Schubert U; Bacík I; Princiotta MF; Wearsch PA; Gibbs J; Day PM; Realini C; Rechsteiner MC; Bennink JR; Yewdell JW
J Cell Biol; 1999 Jul; 146(1):113-24. PubMed ID: 10402464
[TBL] [Abstract][Full Text] [Related]
23. Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines.
Baldeón ME; Neece DJ; Nandi D; Monaco JJ; Gaskins HR
Diabetes; 1997 May; 46(5):770-8. PubMed ID: 9133543
[TBL] [Abstract][Full Text] [Related]
24. PI31 is a modulator of proteasome formation and antigen processing.
Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
[TBL] [Abstract][Full Text] [Related]
25. Generation of major histocompatibility complex class I antigens.
Yang Y
Microbes Infect; 2003 Jan; 5(1):39-47. PubMed ID: 12593972
[TBL] [Abstract][Full Text] [Related]
26. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
[TBL] [Abstract][Full Text] [Related]
27. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
[TBL] [Abstract][Full Text] [Related]
28. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
López D; Del Val M
J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
[TBL] [Abstract][Full Text] [Related]
29. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
Kloetzel PM; Ossendorp F
Curr Opin Immunol; 2004 Feb; 16(1):76-81. PubMed ID: 14734113
[TBL] [Abstract][Full Text] [Related]
30. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
[TBL] [Abstract][Full Text] [Related]
31. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
32. KEKE motifs. Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors.
Realini C; Rogers SW; Rechsteiner M
FEBS Lett; 1994 Jul; 348(2):109-13. PubMed ID: 8034024
[TBL] [Abstract][Full Text] [Related]
33. The function of the proteasome system in MHC class I antigen processing.
Stoltze L; Nussbaum AK; Sijts A; Emmerich NP; Kloetzel PM; Schild H
Immunol Today; 2000 Jul; 21(7):317-9. PubMed ID: 10950502
[No Abstract] [Full Text] [Related]
34. Degradation of cell proteins and the generation of MHC class I-presented peptides.
Rock KL; Goldberg AL
Annu Rev Immunol; 1999; 17():739-79. PubMed ID: 10358773
[TBL] [Abstract][Full Text] [Related]
35. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
André P; Groettrup M; Klenerman P; de Giuli R; Booth BL; Cerundolo V; Bonneville M; Jotereau F; Zinkernagel RM; Lotteau V
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13120-4. PubMed ID: 9789051
[TBL] [Abstract][Full Text] [Related]
36. Generation, translocation, and presentation of MHC class I-restricted peptides.
Heemels MT; Ploegh H
Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
[TBL] [Abstract][Full Text] [Related]
37. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
38. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
39. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome.
Groettrup M; Standera S; Stohwasser R; Kloetzel PM
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):8970-5. PubMed ID: 9256419
[TBL] [Abstract][Full Text] [Related]
40. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
